NAEAP Symposium, Jan 1, 2020: Vets Consider 2.5% Polyacrylamide Gel (PAAG)Treatment

Report from NEAEP Symposium 2019 on the use of 2.5% PAAG

This article was Posted by Stephanie L. Church, Editor-in-Chief | Jan 1, 2020 | 2019 NEAEP Symposium, Arthritis & Degenerative Joint Disease, Arthritis & Degenerative Joint Disease, Article, Horse Care, Lameness, Older Horse Care Concerns.

In a “new uses for old things” twist, an equine veterinarian in Qatar, Dr Florent David, has reported that a 2.5% hydrogel originally designed as a cosmetic filler can help horses with early stage to chronic osteoarthritis (OA) and could even one day be used to help prevent joint damage.

Florent David, DVM, MS, Dipl. ACVS & ECVS, Dipl. ACVSMR, ECVDI Assoc., specialist in Surgery, Sports Medicine & Rehabilitation, and Diagnostic Imaging at the Equine Veterinary Medical Center, in Doha, described what he found in published research on the product at the 2019 Northeast Association of Equine Practitioners Symposium, held Sept. 25-27 in Saratoga Springs, New York.

https://thehorse.com/183011/early-stage-equine-oa-vets-consider-2-5-polyacrylamide-gel-treatment/

Arthramid Hydrogel
About

Learn More

Case Selection & Management
FAQ

Learn More

Clinical Studies
CaseStudies

Learn More

Contact Us

Get In Touch

First Name:
Last Name:
Your Email:
Phone:
Business Name:
Subject:

32 Hill Road, Cambridge, NZ Phone +64 (09) 8013 253 sales@imsvet.com

Arthramid Vet New Zealand

Registered in New Zealand to: Innovative Medical Solutions Limited NZBN: 9429041325544, 32 Hill Road, Cambridge 3494, New Zealand. Registered pursuant to the ACVM Act 1997 Number A11596. See www.foodsafety.govt.nz  for registration conditions.

32 Hill Road, Cambridge
PO Box 1083, Cambridge 3450
Phone +64 (027) 281 4329
Contact@imsvet.com